ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two ...

Upadacitinib, a drug used to treat atopic dermatitis (AD), may potentially induce alopecia areata, a case study suggests.

Black people in the US are not only more likely than other folks to get eczema in childhood, but may have harder-to-treat or ...

Irish startup Luminate is developing a helmet that applies pressure across the surface of the scalp to reduce hair loss ...

ZORYVE foam represents the first topical treatment for seborrheic dermatitis with a new mechanism of action approved in Canada in over two decades1Second approval of ZORYVE outside of the United ...

Results of a retrospective real-world study suggested no greater risk for major CV adverse events in patients treated with ...

Ozempic and other semaglutide medications for weight loss have been linked to hair loss on social media. Experts share who is ...

A study of ruxolitinib cream in patients with lichen planus indicated that the topical JAK inhibitor is a promising potential ...

As previously reported in Women’s Health, semaglutide injections mimic the effects of a hormone called glucagon-like ...

Ozempic and other semaglutide medications for weight loss have been linked to hair loss on social media. Experts share who is ...